What is the recommended dose of fluconazole (antifungal medication) for various fungal infections?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Fluconazole Dosing for Fungal Infections

For systemic candidiasis, use a loading dose of 800 mg (12 mg/kg) on day 1, followed by 400 mg (6 mg/kg) daily maintenance dosing. 1, 2, 3

Oropharyngeal Candidiasis

  • Loading dose: 200 mg on day 1 2, 4, 3
  • Maintenance: 100 mg once daily for 7-14 days 2, 5, 4, 3
  • For moderate to severe disease, doses up to 200 mg daily may be used 5, 4
  • Continue treatment for at least 2 weeks to decrease relapse likelihood 3
  • Important caveat: Relapse rates approach 40% in immunocompromised patients (particularly AIDS patients), who typically require long-term maintenance therapy 6, 7

Esophageal Candidiasis

  • Loading dose: 200 mg on day 1 5, 4, 3
  • Maintenance: 100 mg once daily 5, 3
  • Doses up to 400 mg daily may be used based on clinical response 5, 3
  • Duration: Minimum 14-21 days and at least 2 weeks following symptom resolution 2, 5, 3

Systemic Candida Infections (Candidemia, Disseminated Candidiasis)

  • Loading dose: 800 mg (12 mg/kg) on day 1 1, 2
  • Maintenance: 400 mg (6 mg/kg) daily 1, 2, 5, 3
  • Duration: Continue for 2 weeks after first negative blood culture and resolution of symptoms 1, 4
  • For candidemia without persistent fungemia or metastatic complications, treat for 2-3 weeks after neutropenia resolution and negative cultures 1
  • Critical action: Central venous catheter removal is strongly recommended 2, 4

CNS Candidiasis

  • Dose: 400-800 mg (6-12 mg/kg) daily for patients unable to tolerate amphotericin B 1, 2
  • Continue until all signs, symptoms, CSF abnormalities, and radiologic findings resolve 1
  • Removal of intraventricular devices is recommended 1

Urinary Tract Infections

Symptomatic Cystitis

  • Dose: 200 mg (3 mg/kg) daily for 14 days 1, 2, 5, 4

Pyelonephritis

  • Dose: 200-400 mg (3-6 mg/kg) daily for 14 days 1, 2, 5, 4
  • If disseminated candidiasis is suspected, treat as candidemia 1

Asymptomatic Cystitis

  • Therapy usually not needed 1
  • Exception: Treat high-risk surgical patients, neonates, or neutropenic patients as disseminated candidiasis 1

Chronic Disseminated Candidiasis

  • Dose: 400 mg (6 mg/kg) daily 2
  • Duration: Continue until lesions resolve, typically 3-6 months 1, 2
  • Can be used as step-down therapy in stable patients 1

Vaginal Candidiasis

  • Single dose: 150 mg as a single oral dose 3, 8
  • This provides approximately 75-84% clinical cure rates 6, 8

Cryptococcal Meningitis

  • Treatment: 400 mg on day 1, followed by 200 mg once daily 3
  • Doses up to 400 mg daily may be used based on response 3
  • Duration: 10-12 weeks after CSF becomes culture negative 3
  • Maintenance (AIDS patients): 200 mg once daily to prevent relapse 3

Pediatric Dosing Conversion

  • 3 mg/kg ≈ 100 mg adult dose 2, 4
  • 6 mg/kg ≈ 200 mg adult dose 4
  • 12 mg/kg ≈ 400 mg adult dose 1
  • Absolute doses exceeding 600 mg/day are not recommended in children 3

Critical Species-Specific Considerations

Fluconazole has NO activity against Candida krusei and variable activity against C. glabrata—confirm susceptibility before use. 2, 5

  • C. parapsilosis: Fluconazole is appropriate; if echinocandin used initially, consider switching to fluconazole 1
  • C. glabrata: Use echinocandin or amphotericin B initially; only switch to fluconazole if susceptibility confirmed and patient clinically improved 1
  • C. krusei: Use echinocandin, amphotericin B, or voriconazole—fluconazole is NOT effective 1

Common Pitfalls to Avoid

  • Respiratory secretions: Candida isolated from respiratory tract usually represents colonization, not infection—treatment rarely required 5, 4
  • Inadequate treatment duration: Leads to relapse; continue until clinical and laboratory parameters indicate resolution 2
  • Resistance development: Particularly problematic in patients with recurrent or chronic infections 4
  • Neutropenic patients: Require longer treatment duration (2 weeks after neutropenia resolution) 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Fluconazole Dosing Guidelines for Fungal Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Fluconazole Dosing for Fungal Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Fluconazole Dosing Guidelines for Fungal Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Efficacy and safety of a single oral 150 mg dose of fluconazole for the treatment of vulvovaginal candidiasis in Japan.

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2015

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.